SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-054376
Filing Date
2010-06-01
Accepted
2010-05-28 21:36:49
Documents
8
Period of Report
2010-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c01886e8vk.htm 8-K 42199
2 EXHIBIT 2.1 c01886exv2w1.htm EX-2.1 463115
3 EXHIBIT 10.1 c01886exv10w1.htm EX-10.1 48153
4 EXHIBIT 10.2 c01886exv10w2.htm EX-10.2 102611
5 EXHIBIT 10.3 c01886exv10w3.htm EX-10.3 128637
6 EXHIBIT 99.1 c01886exv99w1.htm EX-99.1 73429
7 EXHIBIT 99.2 c01886exv99w2.htm EX-99.2 33344
8 EXHIBIT 99.3 c01886exv99w3.htm EX-99.3 12991
  Complete submission text file 0000950123-10-054376.txt   906057
Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26483 | Film No.: 10867890
SIC: 2834 Pharmaceutical Preparations